Efficacy of antiplatelets in deep venous thrombosis

Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.

Pharmacy skills will help close the gap in heart disease

With new research showing current cardiovascular disease screening guidelines are missing younger at-risk Aboriginal people, a leading Aboriginal health specialist has highlighted the role...

Broadening pharmacists’ role to improve health

In 2023 pharmacists will be the custodians of medicine safety, embedded wherever medicines are used, and more responsible and accountable for the safe and...

The impact of air pollution

Air pollution is making us sick according to local and global research, including a study linking exposure to air pollution with subsequent acute cardiac...

From the President: For 25 years, accreditation has paved the way

For some, it may be hard to believe; but this month marks 25 years since the start of pharmacist accreditation for medication review in Australia.

2018 PSA Offshore Refresher Conference

Delegates from the 43rd annual PSA Offshore Refresher conference have recently returned from host city San Francisco, where they networked while learning about the...